Private equity firm Ardian said on Tuesday it acquired a 50% stake in specialty chemicals maker ANGUS Chemical Company from Golden Gate Capital for a total enterprise value of about $2.25 billion
San Francisco-based Golden Gate Capital bought ANGUS from The Dow Chemical Company, now Dow Inc ., in February 2015 for more than $1 billion and will retain a 50% stake in the chemicals firm.
Ardian said it expects the sale to close by the end of 2020.
Citi and Guggenheim Securities LLC are serving as financial advisors to Ardian, while Morgan Stanley & Co LLC and JPMorgan Securities LLC are serving as financial advisors to Golden Gate Capital.
Source: Reuters
Can’t stop reading? Read more
Sixth Street-backed Caris Life Sciences targets $5.35bn valuation in US IPO
Sixth Street-backed Caris Life Sciences targets $5.35bn valuation in US IPO Sixth Street-backed...
Advent eyes $5.06bn Spectris takeover in UK’s biggest buyout bid of 2025
Advent eyes $5.06bn Spectris takeover in UK’s biggest buyout bid of 2025 Advent International has...
CalPERS posts 11.3% private equity return as $92bn strategy revamp gains traction
CalPERS posts 11.3% private equity return as $92bn strategy revamp gains traction The California...